Chandra P Belani Selected Research

Chandra P Belani Research Topics

Disease

99	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2002
65	Neoplasms (Cancer) 10/2023 - 02/2002
33	Lung Neoplasms (Lung Cancer) 05/2024 - 12/2002
13	Disease Progression 01/2018 - 10/2007
9	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2019 - 03/2010
9	Fatigue 01/2018 - 06/2007
7	Diarrhea 01/2019 - 12/2005
5	Neutropenia 12/2019 - 10/2009
5	Nausea 08/2017 - 06/2002
5	Vomiting 08/2017 - 06/2002
5	Malignant Mesothelioma 01/2009 - 07/2004
4	Breast Neoplasms (Breast Cancer) 04/2023 - 12/2004
4	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2010
4	Mesothelioma 01/2009 - 07/2005
3	Triple Negative Breast Neoplasms 04/2023 - 03/2012
3	Thrombocytopenia (Thrombopenia) 12/2019 - 07/2004
3	Liver Diseases (Liver Disease) 11/2019 - 02/2008
3	Pneumonia (Pneumonitis) 01/2018 - 12/2010
3	Adenocarcinoma 08/2015 - 12/2010
3	Anemia 07/2013 - 06/2002
3	Weight Loss (Weight Reduction) 09/2008 - 09/2005
3	Neoplasm Metastasis (Metastasis) 12/2006 - 11/2004
2	Hyponatremia 12/2019 - 01/2010
2	Febrile Neutropenia 12/2019 - 05/2010
2	Carcinogenesis 01/2019 - 01/2004
2	Hemorrhage 01/2019 - 10/2007
2	Esophagitis 08/2017 - 09/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2014 - 08/2004
2	Lymphopenia (Lymphocytopenia) 07/2014 - 07/2013
2	Hypertension (High Blood Pressure) 04/2014 - 08/2010
2	Dyspnea (Shortness of Breath) 07/2013 - 09/2008
2	Ovarian Neoplasms (Ovarian Cancer) 03/2012 - 05/2010
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2012 - 05/2010
2	Lymphoma (Lymphomas) 03/2012 - 02/2011
2	Pain (Aches) 03/2012 - 09/2008
2	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 10/2011 - 05/2011
2	Infections 12/2010 - 12/2005
2	Liver Neoplasms (Liver Cancer) 09/2009 - 08/2008
2	Carcinoma (Carcinomatosis) 06/2008 - 12/2005
1	Adenocarcinoma of Lung 04/2022
1	Inflammation (Inflammations) 01/2021

Drug/Important Bio-Agent (IBA)

25	Paclitaxel (Taxol)FDA LinkGeneric 04/2023 - 01/2002
23	Carboplatin (JM8)FDA LinkGeneric 04/2023 - 01/2002
18	Docetaxel (Taxotere)FDA Link 01/2016 - 01/2002
15	PlatinumIBA 01/2022 - 05/2002
15	Cisplatin (Platino)FDA LinkGeneric 08/2017 - 01/2002
12	ErbB Receptors (EGF Receptor)IBA 04/2022 - 10/2003
11	Pemetrexed (MTA)FDA Link 10/2019 - 07/2005
9	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2007
7	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 12/2004
7	Tyrosine Kinase InhibitorsIBA 01/2019 - 10/2003
7	Gemcitabine FDA Link 09/2017 - 01/2002
6	veliparibIBA 04/2023 - 03/2012
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2007
6	Bevacizumab (Avastin)FDA Link 10/2019 - 03/2005
6	Gefitinib (Iressa)FDA Link 03/2008 - 05/2003
5	Histone Deacetylase InhibitorsIBA 11/2019 - 06/2007
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 04/2007
5	Vorinostat FDA Link 10/2010 - 06/2007
5	Vinorelbine (Navelbine)FDA LinkGeneric 12/2005 - 06/2002
4	Monoclonal AntibodiesIBA 01/2018 - 10/2007
4	taxaneIBA 08/2015 - 12/2004
4	Taxoids (Taxanes)IBA 05/2014 - 12/2002
4	belotecanIBA 02/2012 - 02/2009
4	tanespimycin (17AAG)IBA 06/2008 - 05/2005
3	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2019
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 03/2012
3	Etoposide (VP 16)FDA LinkGeneric 08/2017 - 07/2015
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2015 - 10/2003
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2014 - 08/2010
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2013 - 05/2005
3	Cetuximab (Erbitux)FDA Link 05/2011 - 03/2008
3	Antineoplastic Agents (Antineoplastics)IBA 10/2009 - 12/2004
2	CytokinesIBA 01/2021 - 01/2019
2	belinostatIBA 11/2019 - 01/2009
2	CrizotinibIBA 01/2016 - 05/2014
2	Platelet-Derived Growth FactorIBA 02/2015 - 02/2008
2	Capecitabine (Xeloda)FDA Link 07/2014 - 04/2005
2	Bortezomib (Velcade)FDA Link 10/2011 - 01/2011
2	Liposomes (Liposome)IBA 03/2011 - 02/2009
2	EnzymesIBA 08/2010 - 03/2007
2	Platinum Compounds (Compounds, Platinum)IBA 01/2010 - 12/2004
2	Folic Acid AntagonistsIBA 10/2009 - 09/2008
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2008 - 12/2004
2	rubitecanIBA 12/2004 - 08/2004
1	Hematoxylin (Haematoxylon)IBA 10/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2023
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2022
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	ChemokinesIBA 01/2021
1	MLN 8237IBA 01/2020

Therapy/Procedure

50	Therapeutics 04/2022 - 02/2002
45	Drug Therapy (Chemotherapy) 12/2019 - 01/2002
13	Radiotherapy 11/2019 - 06/2005
5	Neoadjuvant Therapy 10/2023 - 07/2003
2	Immunotherapy 01/2016 - 05/2014
2	Adjuvant Chemotherapy 06/2013 - 06/2008
2	Induction Chemotherapy 09/2005 - 06/2005